Get started
Author

S. Annie Gai

Observed names: Gai, Shuning, S Annie Gai, Shuning A. Gai, Shuning Gai, Shuning A. Gai
Observed institutions: Howard Hughes Medical Institute, Harvard University, Ragon Institute of MGH, MIT and Harvard, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Stanford University
OpenAlex ID: A5021093151
Yeast surface display for protein engineering and characterization
2007 · S Annie Gai, K Dane Wittrup · Current Opinion in Structural Biology · 391
Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2013 · Brandon Kwong, S. Annie Gai, et al. · Cancer Research · 197
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
2015 · Eric F. Zhu, Shuning A. Gai, et al. · Cancer Cell · 178
PDF
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
2013 · Yiran Zheng, Matthias T. Stephan, et al. · Journal of Controlled Release · 142
PDF
High-affinity lamprey VLRA and VLRB monoclonal antibodies
2009 · Satoshi Tasumi, C. Alejandro Velikovsky, et al. · Proceedings of the National Academy of Sciences · 128
Genome plasticity in Streptomyces: identification of 1 Mb TIRs in the S. coelicolor A3(2) chromosome
2004 · David Weaver, Nitsara Karoonuthaisiri, et al. · Molecular Microbiology · 63
PDF
Engineering persistent interleukin-2 for cancer immunotherapy
2012 · S. Annie Gai · 2
A genomic island of Streptomyces coelicolor with the self-contained regulon of an ECF sigma factor
2018 · Camilla M. Kao, Nitsara Karoonuthaisiri, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Supplementary Figure Legends from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S4 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S2 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S5 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S3 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S7 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S1 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S6 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S3 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S7 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure Legends from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S6 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S5 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S2 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Supplementary Figure S4 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Supplementary Figure S1 from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
PDF
Data from Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
2023 · Brandon Kwong, S. Annie Gai, et al.
Works count: 27
Citation count: 1,102
H-index: 6
I10-index: 6
Year
Topic
Type